These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32236621)

  • 1. Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer.
    Kumamoto T; Yamada K; Yoshida S; Aoki K; Hirooka S; Eto K; Yanaga K; Yoshida K
    Int J Oncol; 2020 Jun; 56(6):1529-1539. PubMed ID: 32236621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
    PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
    Ito D; Yogosawa S; Mimoto R; Hirooka S; Horiuchi T; Eto K; Yanaga K; Yoshida K
    Cancer Sci; 2017 Aug; 108(8):1565-1573. PubMed ID: 28502078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enforced dual-specificity tyrosine-regulated kinase 2 expression by adenovirus-mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer.
    Imaizumi Y; Yoshida S; Kanegae Y; Eto K; Yoshida K
    Cancer Sci; 2022 Mar; 113(3):960-970. PubMed ID: 34932844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.
    Imawari Y; Mimoto R; Hirooka S; Morikawa T; Takeyama H; Yoshida K
    Cancer Sci; 2018 Feb; 109(2):363-372. PubMed ID: 29193658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma.
    Harada E; Yoshida S; Imaizumi Y; Kawamura A; Ohtsuka T; Yoshida K
    Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130600. PubMed ID: 38508285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
    Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
    Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.
    Luo Y; Xie C; Brocker CN; Fan J; Wu X; Feng L; Wang Q; Zhao J; Lu D; Tandon M; Cam M; Krausz KW; Liu W; Gonzalez FJ
    Gastroenterology; 2019 Sep; 157(3):744-759.e4. PubMed ID: 31154022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.
    Yokoyama-Mashima S; Yogosawa S; Kanegae Y; Hirooka S; Yoshida S; Horiuchi T; Ohashi T; Yanaga K; Saruta M; Oikawa T; Yoshida K
    Cancer Lett; 2019 Jun; 451():100-109. PubMed ID: 30851422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells.
    Wang HC; Chen CW; Yang CL; Tsai IM; Hou YC; Chen CJ; Shan YS
    Cancer Immunol Res; 2017 Oct; 5(10):885-897. PubMed ID: 28835422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of serum/glucocorticoid regulated kinase 1 in colorectal tumours is largely independent of promoter hypermethylation.
    Lessi F; Beggs A; de Palo M; Anti M; Macarone Palmieri R; Francesconi S; Gomes V; Bevilacqua G; Tomlinson I; Segditsas S
    PLoS One; 2010 Nov; 5(11):e13840. PubMed ID: 21079778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.
    Semba S; Itoh N; Ito M; Youssef EM; Harada M; Moriya T; Kimura W; Yamakawa M
    Clin Cancer Res; 2002 Dec; 8(12):3824-31. PubMed ID: 12473596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
    Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.
    Mimoto R; Nihira NT; Hirooka S; Takeyama H; Yoshida K
    Cancer Lett; 2017 Jan; 384():27-38. PubMed ID: 27746162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.
    Mimoto R; Imawari Y; Hirooka S; Takeyama H; Yoshida K
    Oncogene; 2017 Mar; 36(13):1862-1872. PubMed ID: 27721402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kindlin-2 interacts with and stabilizes DNMT1 to promote breast cancer development.
    Wang P; Chu W; Zhang X; Li B; Wu J; Qi L; Yu Y; Zhang H
    Int J Biochem Cell Biol; 2018 Dec; 105():41-51. PubMed ID: 30287284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUSAP1 gene silencing inhibits cell proliferation, migration and invasion through inhibiting DNMT1 gene expression in human colorectal cancer.
    Han G; Wei Z; Cui H; Zhang W; Wei X; Lu Z; Bai X
    Exp Cell Res; 2018 Jun; 367(2):216-221. PubMed ID: 29608915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
    Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
    Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.